What drove the intraday spike in B8F.DE stock?

The spike was driven by heavy volume of **45,797.00** shares versus average **605.00**, expanding liquidity and causing a repricing from **€0.32** to **€6.80** intraday. Thin float and tradeable news or block orders commonly cause such moves.

What is Meyka AI's rating for B8F.DE stock and what does it mean?

Meyka AI rates B8F.DE with a score of **58.53/100**, Grade **C+**, Suggestion: **HOLD**. The grade weighs sector and benchmark comparisons, financial growth and analyst signals. This is informational, not investment advice.

What is the 12-month outlook and price target for B8F.DE stock?

Meyka AI's forecast model projects a 12-month target of **€8.50**, implying **25.00%** upside from **€6.80**. This projection is model-based and not guaranteed; downside scenarios remain significant given volatility and earnings deficits.

How should traders manage risk when trading B8F.DE stock intraday?

Use tight position sizing, stop limits and monitor volume and time of day. Given the relative volume **75.70**, rapid reversals and low liquidity can incur wide spreads and slippage; avoid oversized positions and track official company updates.

DE Stocks

B8F.DE Biofrontera AG (XETRA) rises to €6.80 on heavy volume 26 Jan 2026: monitor catalysts

ByHuzaifa Zahoor January 26, 2026

Biofrontera AG’s B8F.DE stock moved sharply intraday on XETRA to €6.80 as volume surged to 45,797.00 shares, well above the 50-day average of 605.00. The advance follows a low open at €0.37 and a previous close of €0.32, creating extreme short-term volatility. Traders are watching liquidity and potential news catalysts while analysts note fundamentals remain mixed for the small-cap dermatology specialist listed in Germany.